RSS   Newsletter   Contact   Advertise with us

Reata Pharmaceuticals appoints vice president

Staff Writer | Irving, Tx., USA | March 27, 2017
Reata PharmaceuticalsMarch 27, 2017, Irving, Tx., USA - Reata Pharmaceuticals, a company focused on lung diseases, announced the appointment of David Chapman as vice president, marketing.
Mr. Chapman joins the company with over 25 years of biopharmaceutical sales, marketing, and market access experience.

Over the past decade, Mr. Chapman served in leadership roles at Relypsa, Boehringer Ingelheim, and Pfizer.

During his tenure at Boehringer Ingelheim, Mr. Chapman served as the Global Marketing lead for an interferon-free asset for hepatitis C and led Global Market Access activities across a broad range of therapeutic areas.

Most recently, he served as the Director of Managed Markets at Relypsa where he led a team of National and Regional Account Managers that gained new or improved access for Veltassa.

Mr. Chapman received a B.S. in Management from Auburn University, Auburn, AL.